Provided by Tiger Trade Technology Pte. Ltd.

Enveric Biosciences

2.37
-0.2600-9.89%
Post-market: 2.400.0300+1.27%19:50 EST
Volume:84.33K
Turnover:201.05K
Market Cap:3.30M
PE:-0.03
High:2.59
Open:2.58
Low:2.14
Close:2.63
52wk High:54.00
52wk Low:2.14
Shares:1.39M
Float Shares:1.28M
Volume Ratio:1.91
T/O Rate:6.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-93.5500
EPS(LYR):-228.4745
ROE:-262.78%
ROA:-133.22%
PB:0.95
PE(LYR):-0.01

Loading ...

Enveric Biosciences Expands At-The-Market Equity Offering Capacity

TIPRANKS
·
17 hours ago

Enveric Biosciences kündigt Aktienplatzierung im Volumen von 1,35 Millionen US-Dollar an

Reuters
·
18 hours ago

Enveric Biosciences: May Offer & Sell Co's Common Stock Having an Aggregate Offering Price of up to $1.3 Mln From Time to Time Through Wainwright

THOMSON REUTERS
·
18 hours ago

Enveric Biosciences Licenses RCANN Trademark Portfolio to TOTEC Pharma

Reuters
·
Jan 29

Enveric Biosciences Expands Collaboration With Totec Pharma Through Trademark License and Option

THOMSON REUTERS
·
Jan 29

Enveric Biosciences Raises Capital Through Equity Offering

TIPRANKS
·
Jan 29

Enveric Biosciences Issues Warrants to Purchase 657,604 Shares in Direct Offering

Reuters
·
Jan 29

Enveric Biosciences Shares Drop Premarket After $1.5M Equity Raising Prices

Dow Jones
·
Jan 28

Enveric to sell 328,802 shares at $4.41 in registered direct offering

TIPRANKS
·
Jan 28

Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Jan 28

Enveric Biosciences Releases Updated Investor Presentation Materials

TIPRANKS
·
Jan 10

Enveric Biosciences Secures U.S. Patent for Novel Neuropsychiatric Treatment Molecules

Reuters
·
Dec 29, 2025

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:43 PM

Reuters
·
Dec 12, 2025

Enveric Biosciences Raises $3.1 Million Through Warrant Exercise

Reuters
·
Dec 12, 2025

Enveric Biosciences Enacts 1-for-12 Reverse Stock Split

Reuters
·
Dec 12, 2025

Crude Oil Moves Lower; Photronics Shares Surge After Q4 Results

Benzinga
·
Dec 11, 2025

What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading?

Benzinga_recent_news
·
Dec 10, 2025

Enveric Biosciences Receives USPTO Notice of Allowance for EVM301 Series Patent Application

Reuters
·
Dec 09, 2025

Enveric Biosciences to Present at Sachs Neuroscience Innovation Forum and Biotech Showcase

Reuters
·
Dec 04, 2025

Enveric Biosciences Receives Fourth Notice of Allowance for Evm401 Series of Drug Candidates

THOMSON REUTERS
·
Nov 26, 2025